Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Oct;65(10):4038–4042. doi: 10.1128/iai.65.10.4038-4042.1997

Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome.

A Neisser 1, H Bernheimer 1, T Berger 1, A P Moran 1, B Schwerer 1
PMCID: PMC175580  PMID: 9317004

Abstract

Seven patients with Miller Fisher syndrome (MFS), six in the acute phase and one in the recovery phase, were investigated for serum antibodies against gangliosides and purified lipopolysaccharides (LPS) from different strains of Campylobacter jejuni, including the MFS-associated serotypes O:2 and O:23. Immunoglobulin G antibodies against gangliosides GT1a and GQ1b were found in five of six patients in the acute phase of disease. Three of these patients also displayed antibodies to ganglioside GD2, a finding not previously reported for MFS. All anti-GT1a- and anti-GQ1b-seropositive patients showed antibody binding to C. jejuni LPS, predominantly to O:2 and O:23 LPS. Antibody cross-reactivity between gangliosides GT1a and GQ1b and O:2 and O:23 LPS was demonstrated by adsorption studies. This cross-reactivity between gangliosides and C.jejuni LPS, which is obviously due to oligosaccharide homologies, may be an important pathogenetic factor in the development of MFS after C. jejuni infection.

Full Text

The Full Text of this article is available as a PDF (970.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aspinall G. O., Fujimoto S., McDonald A. G., Pang H., Kurjanczyk L. A., Penner J. L. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun. 1994 May;62(5):2122–2125. doi: 10.1128/iai.62.5.2122-2125.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aspinall G. O., McDonald A. G., Pang H., Kurjanczyk L. A., Penner J. L. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry. 1994 Jan 11;33(1):241–249. doi: 10.1021/bi00167a032. [DOI] [PubMed] [Google Scholar]
  3. Aspinall G. O., McDonald A. G., Raju T. S., Pang H., Kurjanczyk L. A., Penner J. L., Moran A. P. Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. Eur J Biochem. 1993 May 1;213(3):1029–1037. doi: 10.1111/j.1432-1033.1993.tb17850.x. [DOI] [PubMed] [Google Scholar]
  4. Aspinall G. O., McDonald A. G., Raju T. S., Pang H., Mills S. D., Kurjanczyk L. A., Penner J. L. Serological diversity and chemical structures of Campylobacter jejuni low-molecular-weight lipopolysaccharides. J Bacteriol. 1992 Feb;174(4):1324–1332. doi: 10.1128/jb.174.4.1324-1332.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Aspinall G. O., McDonald A. G., Raju T. S., Pang H., Moran A. P., Penner J. L. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur J Biochem. 1993 May 1;213(3):1017–1027. doi: 10.1111/j.1432-1033.1993.tb17849.x. [DOI] [PubMed] [Google Scholar]
  6. Berlit P., Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol. 1992 Mar;12(1):57–63. [PubMed] [Google Scholar]
  7. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993 Oct;43(10):1911–1917. doi: 10.1212/wnl.43.10.1911. [DOI] [PubMed] [Google Scholar]
  8. Chiba A., Kusunoki S., Shimizu T., Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992 Jun;31(6):677–679. doi: 10.1002/ana.410310619. [DOI] [PubMed] [Google Scholar]
  9. FISHER M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956 Jul 12;255(2):57–65. doi: 10.1056/NEJM195607122550201. [DOI] [PubMed] [Google Scholar]
  10. Jacobs B. C., Endtz H., van der Meché F. G., Hazenberg M. P., Achtereekte H. A., van Doorn P. A. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol. 1995 Feb;37(2):260–264. doi: 10.1002/ana.410370218. [DOI] [PubMed] [Google Scholar]
  11. Kuroki S., Saida T., Nukina M., Haruta T., Yoshioka M., Kobayashi Y., Nakanishi H. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann Neurol. 1993 Mar;33(3):243–247. doi: 10.1002/ana.410330304. [DOI] [PubMed] [Google Scholar]
  12. Mandrell R. E., Apicella M. A. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology. 1993 Apr;187(3-5):382–402. doi: 10.1016/S0171-2985(11)80352-9. [DOI] [PubMed] [Google Scholar]
  13. Moran A. P., Rietschel E. T., Kosunen T. U., Zähringer U. Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J Bacteriol. 1991 Jan;173(2):618–626. doi: 10.1128/jb.173.2.618-626.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Penner J. L., Hennessy J. N., Congi R. V. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur J Clin Microbiol. 1983 Aug;2(4):378–383. doi: 10.1007/BF02019474. [DOI] [PubMed] [Google Scholar]
  15. Rees J. H., Gregson N. A., Griffiths P. L., Hughes R. A. Campylobacter jejuni and Guillain-Barré syndrome. Q J Med. 1993 Oct;86(10):623–634. doi: 10.1093/qjmed/86.10.623. [DOI] [PubMed] [Google Scholar]
  16. Saito M., Kasai N., Yu R. K. In situ immunological determination of basic carbohydrate structures of gangliosides on thin-layer plates. Anal Biochem. 1985 Jul;148(1):54–58. doi: 10.1016/0003-2697(85)90627-x. [DOI] [PubMed] [Google Scholar]
  17. Salloway S., Mermel L. A., Seamans M., Aspinall G. O., Nam Shin J. E., Kurjanczyk L. A., Penner J. L. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. Infect Immun. 1996 Aug;64(8):2945–2949. doi: 10.1128/iai.64.8.2945-2949.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Willison H. J., Almemar A., Veitch J., Thrush D. Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology. 1994 Dec;44(12):2395–2397. doi: 10.1212/wnl.44.12.2395. [DOI] [PubMed] [Google Scholar]
  19. Willison H. J., Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol. 1994 Mar;50(2):159–165. doi: 10.1016/0165-5728(94)90042-6. [DOI] [PubMed] [Google Scholar]
  20. Willison H. J., Veitch J., Paterson G., Kennedy P. G. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):204–206. doi: 10.1136/jnnp.56.2.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yuki N., Handa S., Tai T., Takahashi M., Saito K., Tsujino Y., Taki T. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J Neurol Sci. 1995 May;130(1):112–116. doi: 10.1016/0022-510x(95)00045-4. [DOI] [PubMed] [Google Scholar]
  22. Yuki N., Ichihashi Y., Taki T. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J Neuroimmunol. 1995 Jul;60(1-2):161–164. doi: 10.1016/0165-5728(95)00052-4. [DOI] [PubMed] [Google Scholar]
  23. Yuki N., Sato S., Tsuji S., Ohsawa T., Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology. 1993 Feb;43(2):414–417. doi: 10.1212/wnl.43.2.414. [DOI] [PubMed] [Google Scholar]
  24. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med. 1993 Nov 1;178(5):1771–1775. doi: 10.1084/jem.178.5.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Yuki N., Taki T., Takahashi M., Saito K., Tai T., Miyatake T., Handa S. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope. Infect Immun. 1994 May;62(5):2101–2103. doi: 10.1128/iai.62.5.2101-2103.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yuki N., Taki T., Takahashi M., Saito K., Yoshino H., Tai T., Handa S., Miyatake T. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol. 1994 Nov;36(5):791–793. doi: 10.1002/ana.410360517. [DOI] [PubMed] [Google Scholar]
  27. van der Meché F. G., Schmitz P. I. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med. 1992 Apr 23;326(17):1123–1129. doi: 10.1056/NEJM199204233261705. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES